Sun BioPharma, Inc. Provides Business Update and Reports Q2 2020 Financial Results

    NEXT STORY
    Myovant Sciences Announces Corporate Updates and Financial Results for First Quarter Fiscal Year 2020
    PREV STORY
    Arcturus Therapeutics Announces that it has Initiated Dosing of its COVID-19 STARR™ mRNA Vaccine Candidate, LUNAR-COV19 (ARCT-021) in a Phase 1/2 study
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    invendo medical Announces CE Mark for the invendoscope™ SC200, The World’s First Sterile, Single-Use Endoscope For Colonoscopies

    NEW YORK and KISSING, Germany, Dec. 05, 2016 (GLOBE NEWSWIRE) -- invendo medical GmbH, ...

    author_avatar
    NASDAQ Market News

    Rexahn Pharmaceuticals Presents Clinical Trial Results for Archexin® at the 2016 American Association for Cancer Research Annual Meeting

    Data Featured at Late Breaking and Clinical Trials Session Suggest Potential Dose and Time ...

    author_avatar
    NASDAQ Market News

    MUHC Foundation launches $200M Dream Big Campaign

    author_avatar
    NASDAQ Market News